Stephen Gordon, Chief Financial Officer at TransMedics Group, Inc. (TMDX), sold 5,000 shares at $79.51 ($398K) on 2023-03-01, disclosed to the SEC on 2023-03-02.
Open-market sale of $398k TMDX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TMDX | SELL | 2024-05-08 | $1.9M | — | Filing → |
| TMDX | SELL | 2024-04-02 | $1.1M | — | Filing → |
| TMDX | SELL | 2024-03-12 | $334K | — | Filing → |